NanoCellect Biomedical, Inc. logo

NanoCellect Biomedical, Inc.

Empowering every scientist to make discoveries one cell at a time

29 employees · est. 2009 · San Diego, United States

VS
Samplix logo

Samplix

Reveal cell function with single-cell resolution.

35 employees · est. 2013 · Denmark

NanoCellect Biomedical, Inc. is the older company (2009 vs 2013).

Side-by-Side Comparison

NanoCellect Biomedical, Inc. Samplix
Founded
2009 older 2013
Headquarters
San Diego, United States Denmark
Employees
29 35
Industry
Biotechnology, Health Care, Medical Devices Biotechnology, Information Technology
Funding Stage
Unknown Series Unknown
Total Funding
$75.70M $12.67M
Funding Rounds
7 3
Services
Microfluidic-based Cell Sorting, Image-Guided Cell Sorting, Scientific Content and Publications, Technical Support, Training and Customer Portal Not tracked yet
Target Customers
Research Scientists, Biotechnology Companies, Academic Laboratories, Pharmaceutical Companies, Gene Editing Specialists Not tracked yet
Taxonomy
Biomedical Research, Cell Analysis, Cell Sorting, Microfluidic Technology, Drug Discovery, Single Cell-omics, Cloning, Antibody Discovery Single-cell Analysis, Immunotherapy Research, Double Emulsion Technology, Flow Cytometry, Cell Sorting, Xdrop Technology, Living Cells Encapsulation, Reactive Molecules, Microenvironment, Flow Cytometry And Sorting, Engineered Cell Therapy Research, Protein Engineering, Synthetic Biology Workflows, Cell Interaction, Cell Secretion
Website
nanocellect.com samplix.com
NanoCellect Biomedical, Inc. logo

About NanoCellect Biomedical, Inc.

NanoCellect Biomedical, Inc., established in 2009, aims to enhance cell-based research by offering innovative microfluidic solutions. Its commitment to “Empowering every scientist to make discoveries one cell at a time” highlights its vision to support the biomedical community with reliable and effi...

Samplix logo

About Samplix

Samplix is a Denmark-based biotechnology startup founded in 2013 with a focus on single-cell analysis in immunotherapy research. The company's flagship product, Xdrop, utilizes double emulsion technology to encapsulate living cells and reactive molecules in stable droplets, enabling rapid cell-cell...

We will tell you when either one moves

BounceWatch watches NanoCellect Biomedical, Inc. and Samplix for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at NanoCellect Biomedical... and Samplix — by email.

Frequently Asked Questions

NanoCellect Biomedical, Inc. — Empowering every scientist to make discoveries one cell at a time. Samplix — Reveal cell function with single-cell resolution.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
NanoCellect Biomedical, Inc. has raised $75.70M while Samplix has raised $12.67M.
NanoCellect Biomedical, Inc. and Samplix operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare NanoCellect Biomedical, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at NanoCellect Biomedical, Inc. on 9 Jun 2026, and Samplix on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy